Science Media Centre

Science Media Centre

Science Alert: Experts Respond

Man dies after taking clinical trial drug- Expert reaction

John Kerr posted in on January 18th, 2016.

A man died today after several days in a brain-dead state, after having an adverse reaction to a drug taken as part of clinical trial to establish the safety of the compound. The drug in question was a FAAH (Fatty Acid Amide Hydrolase) inhibitor, manufactured by the Portuguese company Bial as a potential pain treatment. […]

Alzheimer’s drug announcement – expert reaction

John Kerr posted in on July 23rd, 2015.

Scientists are cautiously optimistic about new data indicating the drug solanezumab can slow the progression of Alzheimer’s disease – if provided early. The drug’s developer, pharmaceutical company Eli Lilly, this week announced preliminary findings from clinical trials investigating the drug solanezumab. Combining data from several trials, the researchers were able to show that patients who […]

GSK Ebola vaccine won’t be ready until late 2015 – experts respond

Laura Goodall posted in on October 20th, 2014.

The pharmaceuticals company GlaxoSmithKline (GSK) has said that its potential Ebola vaccine isn’t likely to be ready until late 2015. GSK is one of several companies trying to fast-track a vaccine to prevent the spread of Ebola in West Africa, compressing trials that would normally take up to 10 years into just 12 months. According to GSK’s press […]

Medical ethics and unconscious patients – experts respond

John Kerr posted in on May 14th, 2014.

Should we be concerned over the involvement of unconscious patients in medical research in New Zealand? The front page of today’s New Zealand Herald carried a story on a company seeking ethical approval for an antibiotics ‘non-inferiority’ trial involving comatose patients. The Health and Disability Ethics Committee minutes and the Auckland Women’s Health Council newsletter which […]

NZ Parkinson’s trial on hold – experts respond

John Kerr posted in on February 20th, 2014.

An Auckland biotech company is putting its trial of an experimental Parkinson’s disease treatment on hold following the withdrawal of previous animal research. Living Cell Technologies (LCT) has suspended patient recruitment for a clinical trial testing the xenotransplantation of specially encapsulated pig-derived cells (NTCELL) as a treatment for Parkinson’s disease. Earlier research from the company had […]

Improving Clinical Trials Report – Experts Respond

John Kerr posted in on June 8th, 2011.

Today the Health Select Committee released the final report of its ‘Inquiry into improving New Zealand’s environment to support innovation through clinical trials’, making several key recommendations. The report makes a series of recommendations to improve competitiveness and attractiveness of New Zealand as a location to undertake large scale clinical trials. As well as providing […]

NZBio: Clinical trials in NZ – how do we do more?

Peter Griffin posted in on March 21st, 2011.

New Zealand is good for clinical trials of new treatments and drugs, but a number of barriers are holding back clinical trials in New Zealand, said a panel of speakers at NZBio conference in Auckland today. Listen to the podcast below to hear their views on what needs to happen to encourage more drug companies […]

Copyright 2016 Science Media Centre (New Zealand)

Disclaimer | Privacy Policy